EMA (EU)
GUIDANCE FINAL
Guideline on good pharmacovigilance practices (GVP): Module VII – Periodic safety update report - Explanatory note
Published: 5/22/2026Detected: 5/22/2026
Summary preview
Clarifies how to prepare PSURs for PSUR single assessment (PSUSA), emphasizing clearer benefit–risk evaluation logic, appropriate clinical/scientific judgement, and consistency with GVP Module VII and ICH E2C (R2).
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountOfficial Source Document Source Verified
Access the original document directly from EMA.
More from EMA (EU)
- Pharmacovigilance Risk Assessment Committee (PRAC): 23 - 26 November 202611/23/2026
- Seventeenth meeting of the industry stakeholder platform on the operation of the centralised procedure for human medicines11/20/2026
- EMA annual call with General Practitioner Organisations' representatives11/20/2026
- Digitalisation and artificial intelligence in pharmaceutical manufacturing: Quality Innovation Group (QIG) - Follow-up roundtable meeting11/18/2026
- Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - November 202611/18/2026